Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 FacebookTwitterPinterestEmail previous post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements Related Posts Barrick Backs Hercules in Leviathan-Linked Copper Expansion July 29, 2025 Sranan Gold July 29, 2025 Crypto Market Update: ARK Picks Canadian Staking Partner, PayPal Unveils... July 29, 2025 Allied Critical Metals Announces $4 Million Strategic Non-Brokered Private Placement July 29, 2025 Peter Grandich: Copper, Uranium in “Perfect Storm,” My Strategy Now July 29, 2025 Nickel Price Update: Q2 2025 in Review July 29, 2025
